FC
PRCT icon

FORA Capital’s Procept Biorobotics PRCT Stock Holding History

FORA Capital’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,929
Closed -$1.36M – 550
2024
Q3 		$1.36M Sell
16,929
-174
-1% -$12.4K 0.16% 172
2024
Q2 		$1.04M Buy
17,103
+3,903
+30% +$232K 0.13% 209
2024
Q1 		$652K Sell
13,200
-1,341
-9% -$63.8K 0.05% 288
2023
Q4 		$609K Buy
+14,541
New +$495K 0.05% 311

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

FORA Capital's PRCT Position: Q4 2024 in Review

FORA Capital sold out of Procept Biorobotics (PRCT) in Q4 2024, closing a stake of 16,929 shares — an estimated $1.36M sold.

FORA Capital first reported a position in PRCT in Q4 2023 and held it in 4 quarters. The position peaked at $1.36M in Q3 2024. 281 funds tracked by Wall St. Rank hold PRCT as of Q4 2024.

  • FORA Capital reported no remaining Procept Biorobotics position as of Q4 2024 after selling out during the quarter.
  • FORA Capital sold 16,929 Procept Biorobotics shares in Q4 2024, an estimated $1.36M.
  • FORA Capital first reported a position in Procept Biorobotics in Q4 2023 and held it in 4 quarters.
  • FORA Capital's Procept Biorobotics position peaked at $1.36M in Q3 2024.
  • 281 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2024.

Based on FORA Capital's 13F filing for Q4 2024, filed 14 Feb 2025.